Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1995
05/10/1995EP0651767A1 Biologically active polypeptides derived from an actinomycete
05/10/1995EP0651766A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa
05/10/1995EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
05/10/1995EP0651764A1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor.
05/10/1995EP0651763A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention
05/10/1995EP0651655A1 Blockade of protein c activation reduces microvascular surgical blood loss
05/10/1995EP0651654A1 Lysozyme dimer and compositions containing the same
05/10/1995EP0651652A1 Treatment for sensitive teeth
05/10/1995EP0651651A1 Amylin antagonists and agonists
05/10/1995EP0651650A1 METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
05/10/1995EP0651649A1 Granulocyte colony-stimulating factor solution delivery method
05/10/1995EP0651648A1 Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
05/10/1995EP0651646A1 Therapeutic conjugates of toxins and drugs
05/10/1995EP0651641A1 Novel bioactive compositions, preparation and use thereof
05/10/1995EP0651636A1 Chemotherapy for cancer
05/10/1995EP0651633A1 Phosphopeptides for the treatment of dental calculus
05/10/1995EP0607346A4 Collagen constructs.
05/10/1995EP0557441B1 N-halochitosans, their preparation and uses
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/10/1995EP0477231B1 Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/10/1995EP0400051B1 Polypeptide compounds having growth hormone releasing activity
05/10/1995EP0366718B1 Monoclonal antibodies neutralizing hiv-1
05/10/1995EP0301078B1 Polypeptides with activity against gram-positive and gram-negative bacteria
05/10/1995CN1102438A Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity
05/10/1995CA2135227A1 Method for preventing hair loss and stimulating new hair growth
05/09/1995US5414132 Peptide intermediates
05/09/1995US5414076 DNA encoding gibbon ape leukemia virus receptor
05/09/1995US5414071 Interleukins
05/09/1995US5414014 Methods for efficacious removal of attached, sucking antropods from human dermis
05/09/1995US5414011 Preservative system for ophthalmic formulations
05/09/1995US5413990 N-terminus modified analogs of LHRH
05/09/1995US5413989 Bone morphogenic proteins
05/09/1995US5413918 Gene and method for production of a 40-45-kDa IgA binding protein
05/09/1995US5413914 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases
05/09/1995US5413910 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
05/09/1995US5413797 Controlled release ACTH containing microspheres
05/09/1995US5413791 Collagen-polymer conjugates
05/09/1995CA2135217A1 Use of d-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts
05/09/1995CA2135151A1 Cyclic hexapeptides, their production and use
05/09/1995CA2050293C Acat enzyme inhibitory composition
05/06/1995CA2135123A1 Medicine for preventing and curing bone fracture
05/05/1995CA2134994A1 Use of the 5' regulatory region of the beta-fetoprotein gene for expressing genes in mammalian cells
05/04/1995WO1995011998A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
05/04/1995WO1995011992A1 Antiviral compounds
05/04/1995WO1995011988A1 Compounds with pth activity and recombinant dna vectors encoding same
05/04/1995WO1995011987A1 Chimeric proteins including protease nexin-1 variants
05/04/1995WO1995011984A2 Recombinant adenoviral vector and methods of use
05/04/1995WO1995011982A1 Expression system for eukaryotic cell lines
05/04/1995WO1995011977A2 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
05/04/1995WO1995011975A2 Retroviral superantigens, superantigen peptides, and methods of use
05/04/1995WO1995011972A1 B1k CHAIN OF LAMININ AND METHODS OF USE
05/04/1995WO1995011966A1 Human activated protein c preparation and process for producing the same
05/04/1995WO1995011962A2 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland
05/04/1995WO1995011924A1 Non-antigenic branched polymer conjugates
05/04/1995WO1995011923A1 A novel tumor marker and novel method of isolating same
05/04/1995WO1995011921A1 Bivalent thrombin inhibitors
05/04/1995WO1995011919A2 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE
05/04/1995WO1995011917A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
05/04/1995WO1995011912A2 Biopolymer synthesis utilizing surface activated, organic polymers
05/04/1995WO1995011910A1 2'-amido and 2'-peptido modified oligonucleotides
05/04/1995WO1995011702A1 Prokaryotic expression of mhc proteins
05/04/1995WO1995011701A1 Inhibition of hiv mucosal infection
05/04/1995WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
05/04/1995WO1995011698A1 Method of stabilizing protein c or activated protein c and stabilized composition
05/04/1995WO1995011697A1 Cure accelerator in chondroplasty
05/04/1995WO1995011696A1 Composition for the treatment of autoimmune hepatitis containing thymosin alpha i and a corticosteroid
05/04/1995WO1995011695A1 Dna sequence encoding a polypeptide with anti-tumor properties
05/04/1995WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
05/04/1995WO1995011693A1 Hemoregulatory peptides
05/04/1995WO1995011691A1 Antithrombotic proteins
05/04/1995WO1995011690A1 Desferrioxamine oral delivery system
05/04/1995WO1995011689A1 Use of inhibitors of dipeptidyl-aminopeptidase to block entry of hiv into cells
05/04/1995WO1995011688A1 Method for treating hepatitis b carriers with minimal disease
05/04/1995WO1995011687A1 Therapeutic use of cis-element decoys in vivo
05/04/1995WO1995011684A1 Antagonistic inhibitor against mesenchymal cell growth
05/04/1995WO1995011670A1 Liposomal defensins
05/04/1995WO1995011663A1 Proteinaceous materials and formulations for sunburn cell protection
05/04/1995WO1995006728A3 T cell epitopes of ryegrass pollen allergen
05/04/1995WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions
05/04/1995WO1995003327A3 Peptides for neutralizing the toxicity of lipid a
05/04/1995WO1994028132A3 Opioid receptors: compositions and methods
05/04/1995DE4343431C1 Cosmetic and/or pharmaceutical compositions
05/04/1995DE4337024A1 Medicinal compsns. comprising oxytocin, vasopressin, endorphine(s) and serotonin
05/04/1995CA2203916A1 Proteinaceous materials and formulations for sunburn cell protection
05/04/1995CA2175579A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
05/04/1995CA2175388A1 Bivalent thrombin inhibitors
05/04/1995CA2175380A1 A novel tumor marker and novel method of isolating same
05/04/1995CA2175255A1 Retroviral superantigens, superantigen peptides, and methods of use
05/04/1995CA2175089A1 Prokaryotic expression of mhc proteins
05/04/1995CA2175046A1 Method for treating hepatitis b carriers with minimal disease
05/04/1995CA2174943A1 A new ribosome-inactivating protein isolated from the plant bryonia dioica
05/04/1995CA2174339A1 2'-amido and 2'-peptido modified oligonucleotides
05/04/1995CA2174210A1 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland
05/04/1995CA2173590A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
05/04/1995CA2169453A1 Inhibition of hiv mucosal infection
05/04/1995CA2134745A1 Glycosaminoglycan-synthetic polymer conjugates
05/04/1995CA2134744A1 Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
05/03/1995EP0651055A2 Uses of modified cholinesterase and compositions containing them
05/03/1995EP0651054A1 Virus-inactivated factor Xa preparation
05/03/1995EP0650736A1 Method for sterilizing recombinant human serum albumin pharmaceutical preparation
1 ... 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 ... 3163